HelixVM Launches Second Phase Study: Unveiling Deeper Insights from Provider Interviews

HITLAB TEAM • January 3, 2024

HelixVM is a healthcare marketplace platform that increases patient access to care by doubling physician processing capacity with no additional ancillary staff. In a big leap toward transforming healthcare delivery, HelixVM has progressed to the second phase of its study. The initial phase demonstrated the platform’s prowess in increasing physician capacity and enhancing patient access to healthcare. Now, the focus shifts to an in-depth exploration through interviews with healthcare providers, shedding light on the utility and effectiveness of the HelixVM platform.

HITLAB, a broad-based Healthcare Innovation and Technology Lab, is spearheading this second phase, seeking to glean deeper insights from providers who have experienced first-hand the impact of HelixVM on their medical practice.

This phase involves targeted interviews with healthcare providers who actively engaged with the HelixVM marketplace platform during the initial study. By delving into their experiences, challenges, and successes, the second phase aims to uncover nuanced perspectives on the platform’s effectiveness in revolutionizing healthcare delivery.

Initial Study Highlights

The first phase of the study, conducted by HITLAB, validated the transformative potential of HelixVM across patients, providers, and referral partners. Key findings included:

  1. Significant Enhancements in Provider Effectiveness: A staggering 91% of healthcare providers reported notable improvements in the accessibility of healthcare services, empowering them to adeptly manage a larger patient demographic.
  2. Commendable Benefits of FastTrack Rx for Patients: Acknowledged by 89% of patients, the FastTrack Rx service within HelixVM emerged as a vital asset, expediting the prescription process while adhering to rigorous medical protocols.
  3. Tangible Gains for Referral Partners: A robust 80% of referral partners enthusiastically affirmed that HelixVM positively influenced their business and clientele by refining care coordination, documentation practices, and accelerating patient processing.

Moving Forward: Insights from Providers

The second phase aims to capture more granular insights from healthcare providers, delving into areas such as:

  • Enhancing Patient Interactions: Investigating the current processes of provider consultations, identifying challenges, and exploring opportunities for improvement in order to streamline interactions with patients.
  • Optimizing Information Flow: Learning about performance of HelixVM in record and exchange of information, with a focus on addressing challenges and improving efficiency.
  • Seamless EMR Integration: Soliciting feedback from providers to understand how well the platform integrates with their Electronic Medical Records (EMR) systems, aiming for a streamlined and cohesive user experience.
  • AI-Enhanced Triage and Clinical Decision Support: Examining the capabilities of AI-assisted triage in aiding clinical decision-making, seeking insights into its effectiveness and potential improvements.
  • Time Efficiency in Patient Encounters: Conducting a thorough analysis of patient encounter times and exploring aspects that could contribute to time-saving measures for healthcare providers.
  • Productivity Enhancement: Seeking providers’ perspectives on participation in healthcare delivery models like HelixVM, specifically exploring the potential for additional income and its impact on overall productivity.

Anticipated Impact

The interviews with healthcare providers are expected to provide a comprehensive understanding of HelixVM’s impact on the front lines of healthcare delivery. This deeper insight will not only validate the platform’s efficacy but also contribute to refining and optimizing its features to better serve the diverse needs of healthcare professionals.

In conclusion, the ongoing second phase of the HelixVM study marks a pivotal moment in the quest to redefine healthcare delivery. As we eagerly await the insights gleaned from in-depth interviews with healthcare providers, the initial study’s resounding successes underscore the transformative potential of this virtual healthcare marketplace. With a commitment to addressing healthcare supply challenges and optimizing patient care, HelixVM stands at the forefront of innovation. The forthcoming provider perspectives promise to shape the platform’s future, ensuring its continued efficacy and relevance in the ever-evolving landscape of healthcare.

As we embark on this next chapter, HITLAB and HelixVM teams remain dedicated to pioneering solutions that revolutionize the way healthcare is delivered for providers, patients, and partners alike.

About HelixVM

HelixVM has developed a patent-pending, cloud-based, medical marketplace that leverages AI to deliver fast and seamless virtual health care. We accept most major medical insurance and operate across all 50 states to deliver a revolutionary health care experience that frees both patients and providers from the drudgery of the current health care model. HelixVM patients seamlessly receive same day treatment without a required face-to-face doctor’s visit, from their phone, while using insurance.

Learn more about